,
EP Information manquante 440 94 (21,4%) 94 (21,4%) Dyspnée persistante, n (%) Information manquante, vol.478, p.6 ,
Information manquante 478 29 (6,6%) 215 (48,8%) Anticoagulation long cours, n (%) Information manquante, vol.3, p.8 ,
8%) 119 (24,9%) HTAP post-embolique, n (%) Information manquante 478 21 (4,8%) 234 (53,2%) Délai jusqu'à récidive, vol.478, p.61 ,
ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)Endorsed by the, Circulation, vol.107, issue.2, pp.4-8, 2003. ,
, Eur Heart J, vol.35, pp.3033-73, 2014.
,
Incidence and mortality of venous thrombosis: a population-based study, J Thromb Haemost, vol.5, pp.692-701, 2007. ,
ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE), J Thromb Haemost, vol.5, pp.1455-61, 2007. ,
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients, N Engl J Med, vol.341, pp.793-800, 1999. ,
Triggers of hospitalization for venous thromboembolism, Circulation, vol.125, pp.2092-2101, 2012. ,
Travel as a risk factor for venous thromboembolic disease: a case-control study, Chest, vol.115, pp.440-444, 1999. ,
Incidence of venous thromboembolism and its effect on survival among patients with common cancers, Arch Intern Med, vol.166, pp.458-64, 2006. ,
An association between atherosclerosis and venous thrombosis, N Engl J Med, vol.348, pp.1435-1476, 2003. ,
Venous thromboembolism and atherothrombosis: an integrated approach, Circulation, vol.121, pp.2146-50, 2010. ,
Cardiovascular risk factors and venous thromboembolism: a meta-analysis, Circulation, vol.117, pp.93-102, 2008. ,
,
, Cigarette smoking and the risk of venous thromboembolism: the Tromsø Study, J Thromb Haemost, vol.10, pp.2068-74, 2012.
,
, Smoking and venous thromboembolism: a Danish follow-up study, J Thromb Haemost, vol.7, pp.1297-303, 2009.
Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception, Lancet, vol.341, pp.1575-82, 1995. ,
Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study, J Thromb Haemost, vol.10, pp.2277-86, 2012. ,
Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study, J Thromb Haemost, vol.6, pp.632-639, 2008. ,
Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study, BMJ, vol.346, p.8632, 2013. ,
Antithrombin III deficiency and thromboembolism, Clin Haematol, vol.10, pp.369-90, 1981. ,
Hyperhomocysteinemia as a risk factor for deepvein thrombosis, N Engl J Med, vol.334, pp.759-62, 1996. ,
Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies, Thromb Haemost, vol.104, pp.962-71, 2010. ,
ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE), J Thromb Haemost, vol.5, pp.1455-61, 2007. ,
Are platelet volume indices of clinical use? A multidisciplinary review, Ann Med, vol.44, pp.805-821, 2012. ,
Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, J Thromb Haemost, vol.8, pp.157-62, 2010. ,
Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease, Arterioscler Thromb Vasc Biol, vol.31, pp.1215-1223, 2011. ,
DOI : 10.1161/atvbaha.110.221788
URL : https://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.110.221788
,
High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS), J Thromb Haemost, vol.8, pp.114-134, 2010. ,
Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE), Am J Med, vol.113, pp.636-678, 2002. ,
Dose-related effect of statins in venous thrombosis risk reduction, Am J Med, vol.124, pp.852-861, 2011. ,
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism, N Engl J Med, vol.361, pp.2342-52, 2009. ,
URL : https://hal.archives-ouvertes.fr/ujm-00439704
, Oral Rivaroxaban for Symptomatic Venous Thromboembolism, N Engl J Med, vol.363, pp.2499-510, 2010.
Oral Apixaban for the Treatment of Acute Venous Thromboembolism, N Engl J Med, vol.369, pp.799-808, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00932477
, The Hokusai-VTE Investigators. Edoxaban versus Warfarin for the Treatment of
, Symptomatic Venous Thromboembolism, N Engl J Med, vol.369, pp.1406-1421, 2013.
Edoxaban for the Treatment of Cancer ,
, Associated Venous Thromboembolism, N Engl J Med, vol.378, pp.615-639, 2018.
Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting: Acceptable venous thromboembolism recurrence rates, J Thromb Haemost, vol.8, pp.2313-2318, 2010. ,
Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review, Arch Intern Med, vol.170, pp.1710-1716, 2010. ,
The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism, Ann Intern Med, vol.147, pp.766-74, 2007. ,
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study, BMJ, p.1065, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02050942
Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH), J Thromb Haemost, vol.10, pp.1019-1044, 2012. ,
Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model, Circulation, vol.121, pp.1630-1636, 2010. ,
Venous thromboembolism: risk factors for recurrence ,
, Arterioscler Thromb Vasc Biol, vol.29, pp.298-310, 2009.
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients, Haematologica, vol.92, pp.199-205, 2007. ,
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study, Arch Intern Med, vol.158, pp.585-93, 1998. ,
Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study, Blood, vol.118, issue.18, pp.4992-5001, 2011. ,
Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors, Arch Intern Med, vol.160, pp.769-74, 2000. ,
Patient Outcomes After Deep Vein Thrombosis and Pulmonary ,
, EmbolismThe Worcester Venous Thromboembolism Study, Arch Intern Med, vol.168, p.425, 2008.
The Risk of ,
, Recurrent Venous Thromboembolism in Men and Women, N Engl J Med, vol.350, pp.2558-63, 2004.
High risk of recurrent venous thromboembolism in men, J Thromb Haemost JTH, vol.2, pp.2152-2157, 2004. ,
Venous thromboembolism and ethnicity, Br J Haematol, vol.146, pp.369-83, 2009. ,
Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study, Arch Intern Med, vol.160, pp.761-769, 2000. ,
Age at first venous thromboembolism and risk of recurrence: a prospective cohort study, Medicine (Baltimore), vol.88, pp.366-70, 2009. ,
DOI : 10.1097/md.0b013e3181c29e31
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial, Eur Respir J, pp.51-1701202, 2018. ,
DOI : 10.1183/13993003.01202-2017
URL : https://hal.archives-ouvertes.fr/hal-02059217
Family history for venous thromboembolism and the risk for recurrence, Am J Med, vol.119, pp.50-53, 2006. ,
DOI : 10.1016/j.amjmed.2005.04.043
Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective followup study, J Thromb Haemost, vol.13, pp.2180-2186, 2015. ,
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis, Blood, vol.100, pp.3484-3492, 2002. ,
DOI : 10.1182/blood-2002-01-0108
URL : http://www.bloodjournal.org/content/100/10/3484.full.pdf
Epidemiology and pathophysiology of cancer-associated thrombosis ,
DOI : 10.1038/sj.bjc.6605599
URL : https://www.nature.com/articles/6605599.pdf
, Br J Cancer, vol.102, issue.1, pp.2-9, 2010.
Overweight, obesity, and the risk of recurrent venous thromboembolism, Arch Intern Med, vol.168, pp.1678-83, 2008. ,
DOI : 10.1001/archinte.168.15.1678
URL : https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/770355/ioi80062_1678_1683.pdf
,
Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry, Blood Coagul Fibrinolysis Int J Haemost Thromb, vol.19, pp.159-65, 2008. ,
Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism, Thromb Haemost, vol.100, pp.246-52, 2008. ,
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study, Thromb Haemost, vol.104, pp.498-503, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00722011
Risk factors for recurrent venous thromboembolism in young and middle-aged women, Thromb Res, vol.133, pp.762-769, 2014. ,
DOI : 10.1016/j.thromres.2014.02.017
B blood group: A strong risk factor for venous thromboembolism recurrence, Thromb Res, vol.136, pp.107-118, 2015. ,
DOI : 10.1016/j.thromres.2015.05.002
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients, Haematologica, vol.92, pp.199-205, 2007. ,
Clinical Factors, and Recurrent Venous Thrombotic Events, JAMA, vol.293, p.2352, 2005. ,
Risk of recurrent venous thromboembolism according to baseline risk factor profiles, Blood Adv, vol.2, pp.788-96, 2018. ,
DOI : 10.1182/bloodadvances.2018017160
URL : http://europepmc.org/articles/pmc5894264?pdf=render
D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis, Thromb Haemost, vol.105, pp.837-882, 2011. ,
Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality, J Thromb Haemost, vol.4, pp.1919-1943, 2006. ,
Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis, J Thromb Haemost, vol.8, pp.2436-2478, 2010. ,
Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events, Arch Intern Med, vol.166, pp.2151-2157, 2006. ,
DOI : 10.1001/archinte.166.19.2151
URL : https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/411155/ioi60114.pdf
Predictive Value of Mean Platelet Volume for Pulmonary Embolism Recurrence, Lung, vol.195, pp.497-502, 2017. ,
DOI : 10.1007/s00408-017-0020-7
Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry ,
DOI : 10.1160/th08-05-0339
, Thromb Haemost, vol.100, pp.905-916, 2008.
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome, N Engl J Med, vol.332, pp.993-1000, 1995. ,
Recurrent thrombosis in patients with deep vein thrombosis and/or venous thromboembolism associated with anticardiolipin antibodies, Angiology, vol.57, pp.79-83, 2006. ,
Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review, Blood, vol.122, pp.817-841, 2013. ,
,
, Thrombophilia, clinical factors, and recurrent venous thrombotic events, JAMA, vol.293, pp.2352-61, 2005.
The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism, Arch Intern Med, vol.162, pp.2357-60, 2002. ,
Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism, Thromb Haemost, vol.80, pp.566-575, 1998. ,
Dimer Testing to Determine the Duration of Anticoagulation Therapy, N Engl J Med, vol.355, pp.1780-1789, 2006. ,
Sex, age and normal post-anticoagulation Ddimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension, J Thromb Haemost, vol.8, pp.1933-1975, 2010. ,
D-dimer levels and risk of recurrent venous thromboembolism, JAMA, vol.290, pp.1071-1075, 2003. ,
DOI : 10.1001/jama.290.8.1071
URL : https://jamanetwork.com/journals/jama/articlepdf/197151/JBR30251.pdf
Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study, Blood, vol.115, pp.481-489, 2010. ,
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism, N Engl J Med, vol.350, pp.2257-64, 2004. ,
Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature, Eur Respir J, pp.49-1601792, 2017. ,
Risk factors for chronic thromboembolic pulmonary hypertension, Eur Respir J, vol.33, pp.325-356, 2009. ,
,
, Prevalence and potential determinants of exertional dyspnea after acute pulmonary embolism, Respir Med, vol.104, pp.1744-1753, 2010.
The prognostic value of pro-B-Type natriuretic peptide in acute pulmonary embolism, Thromb Res, vol.131, pp.235-239, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00935984
Prognostic value of troponins in acute pulmonary embolism: a meta-analysis, Circulation, vol.116, pp.427-460, 2007. ,
Prognostic value of neutrophil to lymphocyte ratio in patients with acute pulmonary embolism: a restrospective study, Heart Lung Circ, vol.23, pp.56-62, 2014. ,
Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study, Eur J Intern Med, vol.52, pp.22-29, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02056408
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor, Blood, vol.111, pp.3540-3545, 2008. ,
Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time, Arterioscler Thromb Vasc Biol, vol.20, pp.2024-2032, 2000. ,
Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels, Hum Mol Genet, vol.19, pp.1863-72, 2010. ,